Procept Biorobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Rob… Read more
Procept Biorobotics Corp (PRCT) - Total Assets
Latest total assets as of September 2025: $511.54 Million USD
Based on the latest financial reports, Procept Biorobotics Corp (PRCT) holds total assets worth $511.54 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Procept Biorobotics Corp - Total Assets Trend (2019–2024)
This chart illustrates how Procept Biorobotics Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Procept Biorobotics Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Procept Biorobotics Corp's total assets of $511.54 Million consist of 90.2% current assets and 9.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 62.5% |
| Accounts Receivable | $83.50 Million | 15.6% |
| Inventory | $56.17 Million | 10.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $932.00K | 0.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Procept Biorobotics Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Procept Biorobotics Corp's current assets represent 90.2% of total assets in 2024, an increase from 81.2% in 2019.
- Cash Position: Cash and equivalents constituted 62.5% of total assets in 2024, down from 67.8% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 3.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 15.6% of total assets.
Procept Biorobotics Corp Competitors by Total Assets
Key competitors of Procept Biorobotics Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Procept Biorobotics Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Procept Biorobotics Corp generates 0.42x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Procept Biorobotics Corp is currently not profitable relative to its asset base.
Procept Biorobotics Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.43 | 6.02 | 7.59 |
| Quick Ratio | 7.19 | 5.07 | 7.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $400.31 Million | $ 269.33 Million | $ 95.73 Million |
Procept Biorobotics Corp - Advanced Valuation Insights
This section examines the relationship between Procept Biorobotics Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.08 |
| Latest Market Cap to Assets Ratio | 2.76 |
| Asset Growth Rate (YoY) | 31.9% |
| Total Assets | $534.02 Million |
| Market Capitalization | $1.47 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Procept Biorobotics Corp's assets at a significant premium ( 2.76x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Procept Biorobotics Corp's assets grew by 31.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Procept Biorobotics Corp (2019–2024)
The table below shows the annual total assets of Procept Biorobotics Corp from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $534.02 Million | +31.95% |
| 2023-12-31 | $404.72 Million | +30.84% |
| 2022-12-31 | $309.33 Million | -8.22% |
| 2021-12-31 | $337.02 Million | +167.54% |
| 2020-12-31 | $125.97 Million | +103.20% |
| 2019-12-31 | $61.99 Million | -- |